#ASMB
You have been summoned from labs far and wide!
ASMB x Manchester Cell-Matrix Centre (@mcrcellmatrix.bsky.social) Basement Membrane Workshop
📆3-5 Dec 2026 at @manchester.ac.uk
Alliances will be made
Secrets will be shared
👉https://www.asmb.net/basement-membrane-workshop
#ECMatrix
2026 ASMB Basement Membrane workshop in Manchester!
YouTube video by ASMB - American Society for Matrix Biology
youtube.com
November 2, 2026 at 5:10 PM
🚨 $ASMB
White Nicole S (Chief Manufacturing Officer) sold 2,593 shares at an average price of $19.6160 per common share. (Date: 2026-11-02)
SEC Filing: ASMB
Click to view the official SEC document.
www.sec.gov
November 3, 2026 at 10:31 PM
🚨 $ASMB
Okazaki Jason A (CEO and President) sold 6,202 shares at an average price of $19.6159 per common share. (Date: 2026-11-02)
SEC Filing: ASMB
Click to view the official SEC document.
www.sec.gov
November 3, 2026 at 10:11 PM
🚨 $ASMB
Gaggar Anuj (Chief Medical Officer) sold 2,593 shares at an average price of $19.6160 per common share. (Date: 2026-11-02)
SEC Filing: ASMB
Click to view the official SEC document.
www.sec.gov
November 3, 2026 at 10:19 PM
🚨 $ASMB
Anuj Gaggar, a Officer, filed a notice of intent to sell 2,593 shares of common stock, valued at approximately $50,864.03, on 11/02/2026.
SEC Filing: ASMB
Click to view the official SEC document.
www.sec.gov
November 2, 2026 at 11:35 PM
🚨 $ASMB
Bjorkquist Jeanette M (PFO and PAO) sold 727 shares at an average price of $19.6169 per common share. (Date: 2026-11-02)
SEC Filing: ASMB
Click to view the official SEC document.
www.sec.gov
November 3, 2026 at 10:37 PM
🚨 $ASMB
Nicole S. White, a Officer, filed a notice of intent to sell 2,593 shares of common stock, valued at approximately $50,864.03, on 11/02/2026.
SEC Filing: ASMB
Click to view the official SEC document.
www.sec.gov
November 2, 2026 at 11:40 PM
🚨 $ASMB
Jason A. Okazaki, a Officer, filed a notice of intent to sell 6,202 shares of common stock, valued at approximately $121,657.81, on 11/02/2026.
SEC Filing: ASMB
Click to view the official SEC document.
www.sec.gov
November 2, 2026 at 11:30 PM
Looks like a cathedral window. But, it isn’t❗️
Know what the tiles are?👀
@anamaporras.bsky.social, from @ufresearch.bsky.social is one of the ASMB Image Contest winners and will explain “Myo-saic of the Matrix” at our e-Symposium on Nov 11, 12 pm ET
Register: www.asmb.net/e-symposia
#ECMatrix
October 28, 2026 at 2:54 AM
Crimson blooms in a green thicket. Not a garden. Any guesses?🤔
Neha Dinesh, St. Michel's @utoronto.ca, an ASMB 2026 Image Contest winner, explains “The Collagen Flora”, from her PhD work at @healthsciences.mcgill.ca, at our e-Symposium on Nov 11, 12 pm ET
Register: www.asmb.net/e-symposia
#ECMatrix
October 27, 2026 at 12:57 AM
Assembly Biosciences Doses First Two Participants in Phase 2 Study of Oral NTCP Inhibitor ABI-6250 for Chronic Hepatitis Delta Virus
– Initial data from the Phase 2 study is expected in the fourth quarter of 2027 – SOUTH SAN FRANCISCO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver diseases, today announced dosing of the first two participants in a Phase 2 clinical study of ABI-6250, the company’s investigational oral small-molecule entry inhibitor candidate, in participants with chronic hepatitis delta virus (HDV) infection. The Phase 2 study is expected to enroll approximately 80 participants with chronic HDV infection and will evaluate two once-daily oral dose levels of ABI-6250. The study will evaluate safety, pharmacokinetics, pharmacodynamics and efficacy, including changes from baseline in HDV RNA and alanine aminotransferase levels. Initial data from the study is expected in the fourth quarter of 2027. Chronic HDV infection is the most severe form of viral hepatitis and results in more rapid progression to cirrhosis, liver cancer, decompensated liver disease or death than other forms of hepatitis. Treatment options remain limited, with only one approved therapy, a peptide inhibitor of sodium taurocholate cotransporting polypeptide (NTCP) that requires daily injections, underscoring the need for effective oral treatment options. “Advancing ABI-6250 into Phase...
www.biospace.com
October 30, 2026 at 6:38 AM
Assembly Biosciences Doses First Two Participants in Phase 2 Study of Oral NTCP Inhibitor ABI-6250 for Chronic Hepatitis Delta Virus
– Initial data from the Phase 2 study is expected in the fourth quarter of 2027 – SOUTH SAN FRANCISCO, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral and liver diseases, today announced dosing of the first two participants in a Phase 2 clinical study of ABI-6250, the company’s investigational oral small-molecule entry inhibitor candidate, in participants with chronic hepatitis delta virus (HDV) infection. The Phase 2 study is expected to enroll approximately 80 participants with chronic HDV infection and will evaluate two once-daily oral dose levels of ABI-6250. The study will evaluate safety, pharmacokinetics, pharmacodynamics and efficacy, including changes from baseline in HDV RNA and alanine aminotransferase levels. Initial data from the study is expected in the fourth quarter of 2027. Chronic HDV infection is the most severe form of viral hepatitis and results in more rapid progression to cirrhosis, liver cancer, decompensated liver disease or death than other forms of hepatitis. Treatment options remain limited, with only one approved therapy, a peptide inhibitor of sodium taurocholate cotransporting polypeptide (NTCP) that requires daily injections, underscoring the need for effective oral treatment options. “Advancing ABI-6250 into Phase...
www.biospace.com
October 30, 2026 at 6:38 AM
Two tissues meet, and the cells line up.
Can you tell which⁉️
Marisa Merino from @livunicancer.bsky.social, an ASMB 2026 Image Contest winner, explains “Cellular Constellations at Tissue Boundaries”at our e-Symposium on Nov 11, 12pm ET
Register: asmb.net/e-symposia
#ECMatrix
October 23, 2026 at 6:16 PM
What are you looking at?👀
Take a guess, then come find out if you were right!
Tina Burkhard from @ucusurrey.bsky.social presents “Matrix in 3D,” an ASMB 2026 Image Contest winner, at our e-Symposium: Wed Nov 11, 12pm ET.🔬
Register: www.asmb.net/e-symposia
#ECMatrix #MatrixBiology
October 22, 2026 at 4:54 PM
No lawyer, things have gotten out of hand since #SupremeCourt ruling of April 2025 & astonishingly awful since the #PeggieNHSFife #Tribunal Judge decided that it was better for a KC to be comfortable in addressing a transgender Doctor by her biological ASMB origin throughout. Dr left the country.
October 19, 2026 at 11:09 PM
📰 Violinos e Runeterra: Orquestra da Ação Social pela Música Agita a Final do CBLOL com Músicos Gamers

#Notícias #ASMB #Brasil #gamerscore

🔗 Leia a matéria completa
Violinos e Runeterra: Orquestra da Ação Social pela Música Agita a Final do CBLOL com Músicos Gamers
Confira a notícia no Gamerscore
www.gamerscore.com.br
October 13, 2026 at 7:10 AM
League of Legends: Orquestra com 30 anos de história abre a grande final do CBLOL no Rio de Janeiro

#GamerseGames

Músicos da ASMB levam música clássica à d
https://www.gamersegames.com.br/2026/10/10/league-of-legends-orquestra-com-30-anos-de-historia-abre-a-grande-final-do-cblol-no-rio-de-janeiro/
League of Legends: Orquestra com 30 anos de história abre a grande final do CBLOL no Rio de Janeiro
A decisão do Campeonato Brasileiro de League of Legends (CBLOL), sediada na Arena Carioca 1, no Parque Olímpico do Rio de Janeiro, terá uma abertura sinfônica neste sábado, 10 de outubro de 2026. Músicos selecionados da Ação Social pela Música do Brasil (ASMB) sobem ao palco de um dos principais torneios de E-sports do país, antecedendo o show da rapper e compositora Ebony e os confrontos que definirão o campeão da temporada. Histórias de jogadores entre cordas e partituras O espetáculo ganha contornos especiais porque os próprios instrumentistas compartilham uma forte ligação com o universo de League of Legends. Entre eles, …
www.gamersegames.com.br
October 10, 2026 at 8:32 PM
Small-cap stocks oversold with improving relative strength, Wed Oct 7th - #$XTIA #$DKI #$BIYA #$VRXA #$MNPR #$LX #$LWAY #$DRUG #$ASMB #$RC - More: crystalequityresearch.com/leading-indi... - #smallcap
Leading Indicators, Wednesday October 7, 2026 – Crystal Equity Research
crystalequityresearch.com
October 7, 2026 at 10:05 PM
Registration now open for the #ASMB Workshop on Basement Membranes, which will be in Manchester, UK Dec 2-5. Great lineup of speakers covering all aspects of BM biology. If you would like to be considered for a talk the abstract deadline is Oct 31. www.asmb.net/basement-mem...
Basement Membrane Workshop
www.asmb.net
September 30, 2026 at 4:33 PM
NPAW Rising Star Series🌟

Some Alport Syndrome mutations act like a premature 🛑sign, causing cells to quit building collagen halfway.
Dr. Kohei Omachi (@riken-bdr.bsky.social) makes tRNAs that read past it.

#NPAW2026 #MatrixBiology #RisingStars #LovePostdocs

📽️ youtu.be/hqNz43QvsbU
Interview with Dr. Kohei Omachi | Rising Stars
YouTube video by ASMB - American Society for Matrix Biology
youtu.be
September 25, 2026 at 8:45 PM
NPAW Rising Star Series🌟

Alport syndrome is a typo in a collagen gene & the kidney's filter comes apart.
Dr @decker-st.bsky.social from @utah.edu studies what happens next, and how mitochondria get dragged in.👨‍🔬🥼

📺 youtu.be/rD3tC1qrXCc?...

#NPAW2026 #MatrixBiology #RisingStars #LovePostdocs
Interview with Dr. Stephen Decker | Rising Stars
YouTube video by ASMB - American Society for Matrix Biology
youtu.be
September 25, 2026 at 2:17 AM
NPAW Rising Stars Series🌟

What goes wrong in the bone marrow matrix in Myelodysplastic Syndromes (MDS)?👀
Dr. @akbains.bsky.social studies how faulty stromal signaling reshapes the #ECM in MDS.

📽️ youtu.be/uqVBtzVnPRU?...

#NPAW2026 #MatrixBiology #RisingStars #LovePostdocs
Interview with Dr. Amanpreet Kaur Bains | Rising Stars
YouTube video by ASMB - American Society for Matrix Biology
youtu.be
September 24, 2026 at 3:03 AM
Professor Prada will see you now.

ASMB President Tom Barker stars in our National Postdoc Appreciation Week message, with a supporting cast of very patient postdocs. 👩‍🔬👨‍🔬🔬🧪
No postdocs were harmed in the making of this video.😛
#NPAW2026 #LovePostdocs

youtu.be/vZNdp0Vk1TA?...
American Society of Matrix Biology Message from The President for National Postdoc Appreciation Week
YouTube video by ASMB - American Society for Matrix Biology
youtu.be
September 23, 2026 at 1:50 AM